BIOMARKER FOR DIAGNOSING ASTHMA OR PULMONARY FIBROSIS COMPRISING ANNEXIN-A5 AND USES THEREOF

摘要

The present invention provides a composition for diagnosing asthma or pulmonary fibrosis, comprising an agent measuring the level of a protein of Annexin-A5 or mRNA of a gene thereof; a kit for diagnosing asthma or pulmonary fibrosis, comprising the composition; a method of providing information for the diagnosis of asthma or pulmonary fibrosis; and a screening method for a therapeutic agent for asthma or pulmonary fibrosis. The present invention provides the composition for diagnosing asthma or pulmonary fibrosis to measure and compare the expression levels of proteins or genes of the proteins whose expression levels vary in a patient with asthma or pulmonary fibrosis, thereby enabling an early diagnosis of asthma or pulmonary fibrosis or significantly prognosticating a disease progression thereof. Furthermore, the composition for diagnosing asthma or pulmonary fibrosis according to the present invention enables a non-invasive diagnosis and thus enables a simple and effective method of making an early diagnosis of asthma, worsened severeasthma, or pulmonary fibrosis by a blood test, a urine test, or the like.;COPYRIGHT KIPO 2019